Clinical Trials Browser

Phase 2 × Neoplasm Metastasis × Pamidronate × Clear all

NCT01067989 2015-07-08

Low-Dose/Metronomic(LDM)Chemotherapy for Metastatic Breast Cancer

Phase 2 Terminated

Breast Neoplasms, Neoplasm Metastasis